Phase 1/2Completed
PK and PD Study of NPI-001 and Cysteamine Bitartrate (INCA)
A Phase 1/2 Pharmacokinetic and Pharmacodynamic Study of NPI-001 Oral Solution Compared to Cysteamine Bitartrate in Cystinosis Patients
- Sponsor
- Nacuity Pharmaceuticals, Inc. (Industry)
- Enrollment
- 8 enrolled
- Conditions
- Cystinosis
- Interventions
- Cysteamine Bitartrate; N-Acetylcysteine Amide
- Ages
- children, adults, older adults
- Registry
- NCT05994534
Full record on ClinicalTrials.gov
From the registry
Safety, pharmacokinetics, and pharmacodynamics of NPI-001 oral solution in cystinosis patients compared with cysteamine.
Primary outcomes
- Concentration of Cystine Levels Over Time
History
Last registry update
Primary completion
Started
Registered